Who owns the AUSTEDO XR trademark?

The AUSTEDO XR trademark is owned by AUSPEX PHARMACEUTICALS LLC.

What class is the AUSTEDO XR trademark registered in?

The AUSTEDO XR trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for AUSTEDO XR?

The USPTO serial number for AUSTEDO XR is 97261591.

What is the registration number for AUSTEDO XR?

AUSTEDO XR is registered under USPTO registration number 7414520.

Sealvo

Home Search: AUSTEDO XRAUSTEDO XR #97261591

Back

Updated Oct 9, 2026·18 searches this week

View on USPTO TSDR Find similar marks

AUS

USPTO Trademark Record

REGISTERED

AUSTEDO XR

SN 97261591·Reg 7414520·Filed Feb 10, 2022

Owner AUSPEX PHARMACEUTICALS LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

AUSTEDO XR (Serial No. 97261591), Registration No. 7414520, is a registered US trademark filed on Feb 10, 2022 by AUSPEX PHARMACEUTICALS LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: June 11, 2030

Mark Intelligence

AUSTEDO XR (Reg. #7414520) is a registered US trademark that has been protecting its owner, AUSPEX PHARMACEUTICALS LLC, since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 10, 2022

SERIAL

97261591

REG#

7414520

REGISTERED

Jun 11, 2024

Filing Information

StatusREGISTERED

Filing DateFeb 10, 2022

Serial Number97261591

Registration No.7414520

Registration DateJun 11, 2024

Status DateJun 11, 2024

Published for OppositionDec 19, 2023

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: May 01, 2023

First use in commerce: Jun 01, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

37 events

TEAS CHANGE OF OWNER ADDRESS RECEIVED

May 19, 2026

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

May 19, 2026

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

May 19, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

May 19, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 19, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Apr 11, 2025

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

REGISTERED-PRINCIPAL REGISTER

Jun 11, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 11, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

May 09, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

May 09, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ASSIGNED TO EXAMINER

Apr 08, 2024

ASSIGNED TO EXAMINER

STATEMENT OF USE PROCESSING COMPLETE

Apr 05, 2024

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 04, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Mar 14, 2024

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Mar 14, 2024

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 13, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Dec 19, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 19, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 29, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 17, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 16, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 16, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Nov 14, 2023

ASSIGNED TO LIE

NOTICE OF REVIVAL - E-MAILED

Jun 13, 2023

NOTICE OF REVIVAL - E-MAILED

ASSIGNED TO EXAMINER

Jun 12, 2023

ASSIGNED TO EXAMINER

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Jun 12, 2023

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

Jun 12, 2023

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Jun 12, 2023

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

TEAS PETITION TO REVIVE RECEIVED

Jun 12, 2023

TEAS PETITION TO REVIVE RECEIVED

PETITION TO REVIVE-GRANTED

Jun 12, 2023

PETITION TO REVIVE-GRANTED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 12, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

ASSIGNED TO EXAMINER

Nov 23, 2022

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Nov 23, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 23, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 23, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 15, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 14, 2022

NEW APPLICATION ENTERED

Other Marks by AUSPEX PHARMACEUTICALS LLC

Additional USPTO filings from the same owner.

AUS

AUSTEDO

86492765

AUSPEX PHARMACEUTICALS LLC

REGISTERED

AUS

AUSTEDO

86752573

AUSPEX PHARMACEUTICALS LLC

REGISTERED

AUS

AUSTEDO

86492763

AUSPEX PHARMACEUTICALS LLC

REGISTERED

NOW

NOW IT'S YOUR MOVE

88663758

AUSPEX PHARMACEUTICALS LLC

REGISTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

AUS

AUSTEDO

86492765

AUSPEX PHARMACEUTICALS LLC

REGISTERED

AUS

AUSTEDO

86752573

AUSPEX PHARMACEUTICALS LLC

REGISTERED

AUS

AUSTEDO

86492763

AUSPEX PHARMACEUTICALS LLC

REGISTERED

JAK

JAKAFI XR

99038809

INCYTE HOLDINGS CORPORATION

REGISTERED

Other Marks by Lori Wolfe

Additional USPTO filings handled by the same attorney of record.

MYL

MY LITTLE SUDOCREM

79430940

REGISTERED

LOG

LogoMark

73561348

REGISTERED

SIM

SIMLANDI

99425494

REGISTERED

SEL

SELARSDI

97477128

REGISTERED

AUSTEDO XR

Run a conflict check

Other Marks by AUSPEX PHARMACEUTICALS LLC

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Lori Wolfe

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company